Patents Examined by Malgorzata A. Walicka
  • Patent number: 6391600
    Abstract: The invention provides PcrA Helicase polypeptides and polynucleotides encodi PcrA Helicase polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing PcrA Helicase polypeptides to screen for antibacterial compounds.
    Type: Grant
    Filed: November 9, 2000
    Date of Patent: May 21, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Damien McDevitt, Earl May, Annemarie St John, Stephanie Van Horn
  • Patent number: 6387688
    Abstract: This invention relates to a Coriolus hirsutus host cell transformed with a vector containing a basidiomycete-derived promoter region selected from the group consisting of basidiomycete-derived ras and priA gene promoter regions. This invention is particularly characterized in that the basidiomycete-derived promoter region is a Lentinus edodes-derived ras or priA gene promoter region or a Coriolus hirsutus-derived ras gene promoter region. This host cell can be utilized for the high productivity of lignin degrading enzymes.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: May 14, 2002
    Assignee: Oji Paper Co., Ltd.
    Inventors: Kazuo Shishido, Susumu Kajiwara, Akira Tsukamoto
  • Patent number: 6387647
    Abstract: A method for screening for potential fungicides identifies biochemical or chemical agents that inhibit the formation of the fungal sterol ergosterol by inhibiting cytochrome P450 reductase or reductase related enzymes or proteins involved in its biosynthesis. Test samples are incubated in two yeast strain cultures, and the extent of growth inhibition is compared between them. One culture is supersensitive to cytochrome P450 reductase inhibitors; the yeast strain typically contains a disrupted or deleted cytochrome P450 reductase gene. The other culture is less sensitive to the compounds, typically exhibiting enhanced permeability such as that observed in erg6 mutants. In preferred embodiments, a known cytochrome P450 reductase related electron-transfer protein inhibitor such as keto-conazole, miconazole, dinaconazole or econazole is employed as a positive control. Preferred embodiments employ solidified media, and test samples are applied to disks or wells.
    Type: Grant
    Filed: September 5, 1995
    Date of Patent: May 14, 2002
    Assignee: BASF Aktiengesellschaft
    Inventors: Donald Richard Kirsch, Margaret Hsien-Fen Kuh Lai
  • Patent number: 6368820
    Abstract: An improved process for production of an N-acylated cephalosporin is described. The process utilizes an Acremonium strain which has been modified to express an acyl transferase of a filamentous fungus and is selected for production of the N-acylated cephalosporin at a level which is equal to or higher than the production of the corresponding &agr;-aminoadipyl-7-cephalosporins in the strain.
    Type: Grant
    Filed: January 15, 1999
    Date of Patent: April 9, 2002
    Assignee: DSM N.V.
    Inventors: Roelof Ary Lans Bovenberg, Dirk Schipper, Richard Kerkman
  • Patent number: 6342380
    Abstract: Germacrene C synthase genes from Lycopersicon esculentum have been cloned and sequenced. Transgenic expression of germacrene C synthase in plants can result in beneficial and useful characteristics such as increased host resistance to pathogens and herbivores and altered flavor and odor profiles.
    Type: Grant
    Filed: September 19, 2000
    Date of Patent: January 29, 2002
    Assignees: The Regents of the University of California, Washington State Research Foundation
    Inventors: Sheila M. Colby, John E. Crock, Peggy G. Lemaux, Rodney B. Croteau
  • Patent number: 6331430
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKif9, antibodies to HsKif9, methods of screening for HsKif9 modulators using biologically active HsKif9, and kits for screening for HsKif9 modulators.
    Type: Grant
    Filed: August 8, 2000
    Date of Patent: December 18, 2001
    Assignee: Cytokinetics, Inc.
    Inventors: Christophe Beraud, Richard Freedman
  • Patent number: 6309867
    Abstract: The present invention is directed to novel telomerase nucleic acids and amino acids. In particular, the present invention is directed to nucleic acid and amino acid sequences encoding various telomerase protein subunits and motifs, including the 123 kDa and 43 kDa telomerase protein subunits of Euplotes aediculatus, and related sequences from Schizosaccharomyces, Saccharomyces sequences, and human telomerase. The present invention is also directed to polypeptides comprising these telomerase protein subunits, as well as functional polypeptides and ribonucleoproteins that contain these subunits.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: October 30, 2001
    Assignee: University Technology Corporation
    Inventors: Thomas R. Cech, Toru Nakamura
  • Patent number: 6309872
    Abstract: The present invention relates to isolated polypeptides having glucoamylase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: November 1, 2000
    Date of Patent: October 30, 2001
    Assignee: Novozymes Biotech, Inc
    Inventors: Michael W. Rey, Elizabeth J. Golightly
  • Patent number: 6284483
    Abstract: The present invention relates to a modified enzyme of a non-heme iron (II) dependent family of oxygenases and oxidases which renders the enzyme dependent on bicarbonate for activity. In a preferred embodiment, the modification is an arginine, lysine, or other amino acid that is two amino acid residues upstream of a histidine residue that is an iron ligand in the enzyme and is one of the histidine residues of the 2-histidine-1-aspartic acid trifacial motif. In particular, the modified enzymes are isopenicillin N synthetase, deacetoxycephalosporin C synthetase, and deacetoxycephalosporin C synthetase/deacetylcephalosporin C synthetase which are used to make antibiotics. The present invention further provides a method for making antibiotics using a modified enzyme such as isopenicillin N synthetase, deacetoxycephalosporin C synthetase, and deacetoxycephalosporin C synthetase/deacetylcephalosporin C synthetase wherein the modification renders the enzyme dependent on bicarbonate for activity.
    Type: Grant
    Filed: October 6, 1999
    Date of Patent: September 4, 2001
    Assignee: Board of Trustees operating Michigan State University
    Inventors: David R. Dilley, Dina K. Kadyrzhanova, Zhenyong Wang, Toni M. Warner
  • Patent number: 6271031
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a quinolinate metabolic enzyme. The invention also relates to the construction of a chimeric gene encoding all or a portion of the quinolinate metabolic enzyme, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the quinolinate metabolic enzyme in a transformed host cell.
    Type: Grant
    Filed: August 9, 1999
    Date of Patent: August 7, 2001
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Savero Carl Falco, Layo O. Famodu, J. Antoni Rafalski